theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Medical Oncology

ctDNA   

Questions discussed in this category


How do you approach early-stage breast cancer patients who are asking for ctDNA or tumor marker surveillance (or previously receiving these with another provider) when these are not part of the NCCN or ASCO guidelines?
2 Answers available

How would positive ctDNA results after 12 cycles of adjuvant FOLFOX affect your management for patients with colon cancer?
4 Answers available
2202013370


Papers discussed in this category


N Engl J Med, 2022 Jun 04
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

JCO precision oncology, 2022 Jul
Reply to F. Dayyani et al.

Related Topics in Medical Oncology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.